首页> 美国卫生研究院文献>Wiley-Blackwell Online Open >Structure‐Guided Design of Peptides as Tools to Probe the Protein–Protein Interaction between Cullin‐2 and Elongin BC Substrate Adaptor in Cullin RING E3 Ubiquitin Ligases
【2h】

Structure‐Guided Design of Peptides as Tools to Probe the Protein–Protein Interaction between Cullin‐2 and Elongin BC Substrate Adaptor in Cullin RING E3 Ubiquitin Ligases

机译:肽的结构引导设计作为探测Cullin RING E3泛素甘蓝中Cullin-2和Elongin BC底物衔接子之间蛋白质-蛋白质相互作用的工具

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cullin RING E3 ubiquitin ligases (CRLs) are large dynamic multi‐subunit complexes that control the fate of many proteins in cells. CRLs are attractive drug targets for the development of small‐molecule inhibitors and chemical inducers of protein degradation. Herein we describe a structure‐guided biophysical approach to probe the protein–protein interaction (PPI) between the Cullin‐2 scaffold protein and the adaptor subunits Elongin BC within the context of the von Hippel‐Lindau complex (CRL2VHL) using peptides. Two peptides were shown to bind at the targeted binding site on Elongin C, named the “EloC site”, with micromolar dissociation constants, providing a starting point for future optimization. Our results suggest ligandability of the EloC binding site to short linear peptides, unveiling the opportunity and challenges to develop small molecules that have the potential to target selectively the Cul2‐adaptor PPI within CRLs.
机译:Cullin RING E3泛素连接酶(CRL)是大型动态多亚基复合物,可控制细胞中许多蛋白质的命运。 CRL是开发小分子抑制剂和蛋白质降解化学诱导剂的有吸引力的药物靶标。在本文中,我们描述了一种结构指导的生物物理方法,以在von Hippel-Lindau复合物(CRL2 VHL )的背景下探查Cullin-2支架蛋白与衔接子亚基Elongin BC之间的蛋白相互作用。 sup>)使用肽。已显示两种肽以微摩尔解离常数结合在Elongin C的靶向结合位点,称为“ EloC位点”,为将来的优化提供了起点。我们的结果表明EloC结合位点对短线性肽的配位性,揭示了开发小分子的机会和挑战,这些小分子有可能选择性靶向CRL中的Cul2-adapter PPI。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号